Laura Robinette, MD
Pediatrics · Alexandria, VANPI 1104072693
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,410 of the $15,827 with a category attached, or 65.8%. Gilead accounts for 86.8% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $13,735 and has fallen 95.1% since, to $677 in 2025. Among pediatrics clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 133 payments — averaging $119.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$14K
- Viiv Healthcare Company$352
- Pfizer$276
- Takeda Pharmaceuticals U.S.A., Inc.$268
- Supernus Pharmaceuticals, Inc.$234
- Novo Nordisk$193
- plus $769 from 16 others
What the payments were for
- Speaking & faculty fees$10,41066%
- Travel & lodging$2,60816%
- Food & beverage$2,78418%
- Education$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 28 | $13,736 |
| Viiv Healthcare Company | 17 | $352 |
| Pfizer | 17 | $276 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $268 |
| Supernus Pharmaceuticals, Inc. | 12 | $234 |
| Novo Nordisk | 10 | $193 |
| AbbVie | 5 | $107 |
| Lilly USA, LLC | 4 | $85 |
| AstraZeneca | 5 | $82 |
| Exact Sciences | 3 | $74 |
| Hologic Sales And Service, LLC | 2 | $67 |
| Astellas Pharma US Inc | 4 | $67 |
| Alk-abello, Inc | 2 | $55 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| Currax Pharmaceuticals LLC | 2 | $40 |
| Phadia US Inc. | 2 | $37 |
| Bayer | 1 | $25 |
| Genentech USA, Inc. | 1 | $22 |
| Cranial Technologies, Inc | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $16 |
| Seqirus USA Inc | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,827 in reported general payments places this provider in the 95th percentile of 1,542 pediatrics providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 33 | $37,177 |
| OzempicSemaglutide | 25 | $35,699 |
| JanuviaSitagliptin Phosphate | 16 | $22,240 |
| MounjaroTirzepatide | 14 | $16,685 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 16 | $3,931 |
| Rosuvastatin Calcium | 135 | $2,166 |
| SynthroidLevothyroxine Sodium | 15 | $1,726 |
| Duloxetine Hcl | 21 | $1,564 |
| Levothyroxine Sodium | 99 | $1,501 |
| Atorvastatin Calcium | 123 | $1,293 |
| Metoprolol Succinate | 49 | $751 |
| Sertraline Hcl | 41 | $710 |
| Telmisartan | 15 | $695 |
| Amlodipine Besylate | 100 | $694 |
| Losartan Potassium | 63 | $692 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $276 | $37,17733 claims |
| Novo NordiskOzempic | $193 | $35,69925 claims |
| Lilly USA, LLCMounjaro | $85 | $16,68514 claims |
| AbbVieSynthroid | $107 | $1,72615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,542 pediatrics providers in Virginia.
Other pediatrics in Alexandria
- Martha WelmanAlexandria$30K
- Mehr Zahra ShahAlexandria$3K
- Patricia MulreanyMidlothian$1.5M
- Dominick PastoreRichmond$1.1M
- Judith GrossbergMidlothian$291K
- Elizabeth CullenMidlothian$289K
- Martha SaundersMidlothian$288K
- Anne Marie IraniRichmond$265K
- Ozlem Goker-AlpanFairfax$210K
- Tamara SutherlandGlen Allen$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.